IPNewsletter
   taftlaw | intellectual property practice | subscribe | contact us | forward

Taft's Intellectual Property attorneys handle a wide variety of intellectual property issues, both nationally and internationally. Our attorneys advise clients on intellectual property matters relating to patents, trademarks, copyrights, trade secrets, unfair competition, false advertising, right of publicity, licensing, open source, software and technology, websites and domain names. We have experienced, highly qualified litigators who bring and defend IP related infringement lawsuits throughout the United States.  Clients include Fortune 500 companies, hospitals, universities and research institutions, mid-size and small companies, authors, artists, inventors, scientists, and entrepreneurs. 

CTM: Affordable Trademark Protection Throughout Europe    

 

 

Amy L. Wright

awright@taftlaw.com

(317) 713-3594 

Businesses expanding into Europe have historically been forced to face the difficulty and expense associated with securing national trademark registrations in each country in which they intend to operate.  The Community Trademark (CTM) system was established to streamline this complex multi-national process by creating a single registration that provides protection in all 27 European Union member states.

  

Administered by the Office of Harmonization in the Internal Market (OHIM), the CTM system provides a simple and cost effective alternative to traditional national registrations.  Similar to U.S. federal trademark registrations, CTM registrations last for ten years and may be renewed indefinitely every ten years, so long as the mark remains in genuine use.  Importantly, CTM registrations can co-exist with any antecedent European national registrations owned by the same entity.

   

continue reading  

Phased Implementation of the America Invents Act 

Ryan White
James A. Coles

jcoles@taftlaw.com

(317) 713-3459

 

The America Invents Act (the "Act") was signed into law on September 16, 2011, but only a limited number of sections of the Act were implemented on that date or even shortly thereafter.  Some of the more significant sections will not be implemented until September 16, 2012 and those sections related to first-to-file will not be implemented until March 16, 2013.  So there is time for businesses to evaluate and plan for the implementation of many sections of the Act.

 

continue reading  

Termination Determination: Molecules Matter 

 

Adelaide K. Leitzel, Ph.D.

leitzel@taftlaw.com  

(513) 357-9669

 

In 2008, the biosciences sector employed over 1.42 million people and is one of the few areas of growing employment during this economic downturn.  The biosciences sector encompasses companies built on DNA-related technology.  Inventors and companies protect their DNA related technology with over 40,000 DNA related patents.  Recently the Association for Molecular Pathology (AMP), the ACLU and other parties filed a lawsuit against Myriad Genetics alleging that patents covering isolated DNA are invalid.  The AMP and the ACLU appeared victorious when the U.S. District Court for the Southern District of New York ruled that the Myriad patents were invalid.  Myriad Genetics, a company started by one of the inventors of the patents in question, appealed the district court's decision.  On July 29, 2011 the United States Court of Appeals for the Federal Circuit (CAFC) affirmed the patentability of DNA and salvaged an industry structured on over 2700 patents claiming "isolated DNA".  

 

continue reading 
  


Taft's Intellectual Property Newsletter is used to inform our clients and friends of significant new developments and current issues in intellectual property law. For more information about Taft Stettinius & Hollister LLP, please visit http://www.taftlaw.com.

These materials have been prepared by Taft Stettinius & Hollister LLP for informational purposes only and are not legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. No person or organization should act upon this information without first seeking professional counsel.

We cannot and do not represent you until our client intake process is completed. Further, we reserve the right to accept or decline representing any person or organization in any matter. Accordingly, please do not send us any confidential information about any matter until you receive a written statement from us advising you that we represent you (an "engagement letter"). When you receive an engagement letter from one of our attorneys, you will be our client, and we may exchange confidential information freely. Again, do not send us unsolicited confidential information until you speak with one of our attorneys and get authorization to send that information to us.

Some aspects of this Web site may allow you to register for newsletters, events, functions, or seminars hosted by, sponsored by, or associated with Taft Stettinius & Hollister LLP. The transmission or receipt of any information related to registration for any event or service does not create an attorney-client relationship.

Taft Stettinius & Hollister LLP's Web site and associated materials may provide links to other websites that may be useful or informative.These links to third party sites or information are not intended, and should not be interpreted by readers, as constituting or implying our endorsement, sponsorship or recommendation of the third party information, products or services found there.

The following statement is required by many states, including Kentucky: "THIS IS AN ADVERTISEMENT."
April 2012 Issue
CTM: Affordable Trademark Protection Throughout Europe
Phased Implementation of the America Invents Act
Termination Determination: Molecules Matter






This email was sent to ksharpe@taftlaw.com by taft@taftlaw.com |  
Instant removal with SafeUnsubscribe | Privacy Policy.
Taft Stettinius & Hollister LLP | 425 Walnut Street | Suite 1800 | Cincinnati | OH | 45202